Illumina Inc. (NASDAQ:ILMN) is acquiring fellow genomics company Pacific Biosciences of California (NASDAQ:PACB) for $8 per share in cash, or about $1.2 billion.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,